期刊文献+

过氧化物酶增殖物活化受体γC161→T基因多态性与原发性高血压相关研究 被引量:5

Association between gene polymorphism of peroxisome proliferator-activated receptor gamma C161→T and essential hypertension
原文传递
导出
摘要 目的探讨过氧化物酶增殖物活化受体γ(peroxisome proliferator-activated receptor gamma,PPARγ)C161→T基因多态性与原发性高血压的关系。方法 393例原发性高血压患者(高血压组)与405例体检健康者(对照组),应用聚合酶链反应-限制性片段长度多态性方法分析单核苷酸多态性位点,比较2组多态性频率。结果高血压组基因型分布及等位基因PPARγC161→T分布与对照组比较差异有统计学意义(P<0.05);高血压组T等位基因频率低于对照组(P<0.05)。结论 PPARγC161→T基因多态性与原发性高血压病有相关性。 Abstract: Objective To explore the relationship between gene polymorphism of peroxisome proliferator-activated receptor gamma (PPARγ)Cl61→T and essential hypertension. Methods The gene polymorphism was analyzed by PCR- restriction fragment length polymorphism in 393 patients with essential hypertension and 405 healthy controls. The data of frequency were compared between two groups. Results There were significant differences in distribution of genotype and PPARγCl61→T allele between two groups (P〈0.05). The frequency of T allele was lower in hypertensive patients than that in healthy controls (P 〈0.05). Conclusions PPARγCl61→ T genetic polymorphism is correlated with essential hypertension.
出处 《中华实用诊断与治疗杂志》 2014年第2期134-136,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 高血压 过氧化物酶体增殖物激活受体Γ 多态性 限制性片断长度 Hypertension peroxisome proliferator-activated receptor gamma polymorphism restriction fragment length
  • 相关文献

参考文献15

二级参考文献69

共引文献42

同被引文献30

  • 1曲辅政 ,刘同库 .PPARγC161-T变异与高血压病的相关性临床研究[J].北华大学学报(自然科学版),2005,6(1):58-61. 被引量:3
  • 2杨孜,王伽略,黄萍,石凌懿,李蓉,叶蓉华,陈蕾.重度子痫前期临床发病类型及特点与围产结局的关系[J].中华妇产科杂志,2006,41(5):302-306. 被引量:155
  • 3刘尊敬,杨期东,刘运海,王国相,焦劲松,薛爽,田朝晖,熊新英,龙涛,徐文艳.过氧化小体增殖剂激活型受体γ激活剂对缺血再灌注脑组织的保护作用及炎性机制分析[J].国际神经病学神经外科学杂志,2007,34(2):121-124. 被引量:16
  • 4Stables M J, Gilroy DW. Old and new generation lipid media- tots in acute inflammatory and resolution. Prog Lipid Res, 2011, 50 (1): 35-51.
  • 5Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome p rolifer2 actor activated receptor gam- ma (hPPAR gamma ) gene in diabetic Caucasians: identifica- tion of a Pro l 2 Ala PPAR gamma 2 missensemutation. Bio-them Biophys Res Commun, 1997, 241 (2) : 270-274.
  • 6Arashiro R, Katsuren K, Fukuyama S, et al. Effect d Trp64Arg mutation of the 133- adrenergie receptor gene and C 161 T sub- stitution of the peroxisome proliferator activated reeeptorγgene on obesity in Japanese children. Pediatr Int, 2003, 45: 135-141.
  • 7Olefsky JM. Find all citations by this author ( default ) Or fil- ter your current search Glass CK. Macrophage, inflammation, and insulin resistance. Ann Rev Physiol, 2010, 72 : 219- 246.
  • 8Komatsu A, Node K. Effects of PPAR gamma agonist on dys- lipidemia and atheroscleresis. Nippon Rinsho, 2010, 68 (2) : 294-298.
  • 9Liu Y, Yuan ZY, Liu Y, et al. PPARg gane C 161T sub- stitution is associated with reduced risk of coronary artery dis- ease and decreased proinflammatory cytokine expression. Am Heart J, 2007, 154: 718-724.
  • 10Wu Z, Lou Y, Jin W, et al. The C161T Polymorphism in the peroxisome proliferators-activated receptor gamma gene ( PPARγ ) is associated with risk of coronary artery disease : a mate-analysis. Mol Boil Rep, 2013, 40 ( 4 ) : 3101- 3112.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部